Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes
FULL MENU

Non-invasive assessment of cardiac condition

Non-invasive assessment of cardiac condition

BACK

Non-invasive assessment of cardiac condition

The blood vessels that wrap the heart, called coronaries, become sometime partially obstructed, preventing the blood to circulate properly; such condition tend to worsen with time, producing a number of serious health problems including heart failure.

It has been proven that an instrumental measurement, called Fractional Flow Reserve (FFR), can very effectively recognise the severity of such occlusions, and provide an excellent basis for deciding, in each patient, the most suitable treatment. Unfortunately, the measurement of FFR is and invasive and complex procedure, that only a few hospitals are equipped to perform, and that involve some risks for the patient.

Thus, in spite its efficacy it is rarely used in the clinical practice. A patient-specific vascular modelling technology, emerged from the EU-Heart project, is now being used to estimate the FFR (vFFR) starting from rotational angiography images. After a preliminary on 20 patients was successful, where 19 patients out of 20 were stratified in the same way by FFR and vFFR, the vFFR predictor is now being tested in a mono-centric clinical trial funded by the Wellcome Trust over 100 patients.

Morris PD, Ryan D, Morton AC, Lycett R, Lawford PV, Hose DR, Gunn JP (2013, February). Virtual Fractional Flow Reserve From Coronary Angiography: Modeling the Significance of Coronary Lesions: Results From the VIRTU-1 (VIRTUal Fractional Flow Reserve From Coronary Angiography) Study. J Am Coll Cardiol Intv., 6(2), 149-157. doi:10.1016/j.jcin.2012.08.024
Public dissemination: BBC coverage http://www.youtube.com/watch?v=VutbdlUupVk

IMAGE GALLERY:

NEWS

News Avicenna Alliance Submits MDR Revision Proposals to the European Commission

Avicenna Alliance Submits MDR Revision Proposals to the European Commission

The Avicenna Alliance is pleased to announce that, in a letter sent to the European Commissioner for Health and Animal Welfare, Olivér Várhelyi, we have formally submitted our proposals for the revision of the Medical Devices Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) to the European Commission.

News Advancing In Silico Medicine: Strengthening Dialogue with EU Policymakers

Advancing In Silico Medicine: Strengthening Dialogue with EU Policymakers

On February 17, our President & Secretary General Thierry Marchal, alongside Nayara Maldonado Solís from RPP, had the opportunity to meet with the team of MEP Kulja, MD, to discuss the creation of an MEP In Silico Coalition. This initiative would establish a regular dialogue between in silico experts from the Avicenna Alliance and the VPH Institute, and MEPs committed to new technologies in healthcare.

News Welcome to René Bombien, New Co-Chair of the Clinical Deployment Task Force

Welcome to René Bombien, New Co-Chair of the Clinical Deployment Task Force

The Avicenna Alliance is pleased to welcome René Bombien as the new Co-Chair of the Clinical Deployment Task Force.

Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2025 Avicenna Alliance | powered by We Berry